PDF (84kB) - Nur für Mitarbeiter des Archivs |
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.818
Zusammenfassung
Most of the initial reports on botulinum toxin in tension-type headache (TTH) and in migraine were positive. Unfortunately, these results were not reproduced in well-designed, randomized controlled trials. So far, doses from 20 U (Botox) to 500 U (Dysport) have been studied in patients with chronic TTH, and doses from 16 to 200 U (Botox) in patients with migraine. Overall, there is no evidence ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags